Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Telecoms

GCV Asia Congress Awards 2017 - New Entrant of the Year: AddVentures

AddVentures, the corporate venturing arm of Thai conglomerate Siam Cement Group (SCG), has been named new entrant of the year in the 2017 Global Corporate Venturing Asia Congress awards. The fund was set up in June this year and will be funded by SCG to the tune of up to $85m over the next three to five years.


Sep 19, 2017

GCV Asia Congress Awards 2017 - Unit of the Year: Tencent Investment

The huge strides made by Tencent Investment since 2015 are largely the result of its increased appetite for dealmaking on a grand scale as well as its willingness to look outside of China for new ventures.

Sep 19, 2017

Editorial: Update on GCV Rising Stars shows promotions and changes

For potential nominations to the 2018 GCV Rising Stars list, please contact me at jmawson@mawsonia.com

Sep 16, 2017

Analysis: 23andMe raises $250m

Genetics services company 23andMe, previously backed by Alphabet, Illumina, WuXi PharmaTech and Johnson and Johnson, secured a large $250m round.

Sep 14, 2017

Federated Wireless mobilises investors to raise $42m

Charter Communications, American Tower and Arris International co-led a series B round for the telecom spectrum management platform, which is now valued at $122m, with GIC.

Sep 14, 2017

The ins and outs of exits

A special report on the venture endgame

Sep 13, 2017

Brazil breezing through macro headwinds

Over the past few weeks and months, the country has seen positive headlines for large deals, venture fundraising and corporate innovation initiatives

Sep 13, 2017
Sep 12, 2017

Analysis: NeoTract to be acquired for $1.1bn

Medical device producer NeoTract has agreed to be acquired by Teleflex for $1.1bn, giving an exit to Johnson & Johnson, a notable deal in a field where corporate commitments have been on the rise.

Sep 8, 2017
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here